Bacterial Vaginosis
New Study Finds Tindamax to be Effective, Well-Tolerated Treatment for Bacterial Vaginosis
Published in Drug Week, August 17th, 2007
A study published in the August issue of Obstetrics & Gynecology, the official publication of the American College of Obstetricians and Gynecologists (ACOG), finds that Mission Pharmacal's Tindamax(R) (tinidazole) is an effective and well-tolerated treatment for bacterial vaginosis (BV), the most common vaginal infection among women of childbearing age in the United States. BV affects almost one-third of women in the United States and is one of the main causes of the 10 million doctor visits for vaginitis in the country annually.
The randomized, double-blinded study found that a 1 gram once daily, five- day course of treatment with Tindamax resulted in a therapeutic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-08-17)
More Articles from Drug Week
- Anemia
Nutritional supplement cuts anemia in poor children by half - Cardiology
Mailman School of PH receives $23M to lead network evaluating cardiac interventions - Colon Cancer
Colorectal cancer research surges at Vanderbilt-Ingram Cancer Center - Depression
Sex Differences Found in COPD - Dermatology
Use of Increasingly Popular Treatment for Wound Healing Questioned - Drug Resistance
Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
